{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:09:39Z","timestamp":1757617779342,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 15-year-old boy with congenital mitochondrial disease was diagnosed with acute promyelocytic leukemia. He was treated with all-trans retinoic acid, and his anthracycline dose was reduced in response to his underlying condition. He successfully achieved molecular remission and maintained this state for 4\u00a0years. In vitro drug sensitivity testing in peripheral mononuclear cells suggests that samples from patients in remission show higher sensitivity to various anticancer drugs than samples from healthy volunteers. Reduced-dose chemotherapy could be a valid treatment option for patients with mitochondrial diseases because exposure to elevated oxidative stress may contribute to increased drug sensitivity in these patients.<\/jats:p>","DOI":"10.1007\/s12185-025-03992-4","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:57:35Z","timestamp":1746089855000},"page":"301-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of acute promyelocytic leukemia complicated by mitochondrial disease"],"prefix":"10.1007","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5541-7212","authenticated-orcid":false,"given":"Yukari","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Yanagimachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayana","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Keino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hamanoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masae","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"3992_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s10541-005-0102-7","volume":"70","author":"AY Andreyev","year":"2005","unstructured":"Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochem Mosc. 2005;70:200\u201314.","journal-title":"Biochem Mosc"},{"key":"3992_CR2","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","volume":"348","author":"S DiMauro","year":"2003","unstructured":"DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656\u201368.","journal-title":"N Engl J Med"},{"key":"3992_CR3","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","volume":"77","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Sproule DM, et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology. 2011;77:1965\u201371.","journal-title":"Neurology."},{"key":"3992_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/bjc.2015.66","volume":"112","author":"M Lund","year":"2015","unstructured":"Lund M, Melbye M, Diaz LJ, Duno M, Wohlfahrt J, Vissing J. Mitochondrial dysfunction and risk of cancer. Br J Cancer. 2015;112:1134\u201340.","journal-title":"Br J Cancer"},{"key":"3992_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"3992_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1073\/pnas.0408894102","volume":"102","author":"JA Petros","year":"2005","unstructured":"Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A. 2005;102:719\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3992_CR7","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jcp.25349","volume":"231","author":"Y Yang","year":"2016","unstructured":"Yang Y, Karakhanova S, Hartwig W, D\u2019Haese JG, Philippov PP, Werner J, et al. Mitochondria and mitochondrial ROS in cancer: Novel targets for anticancer therapy. J Cell Physiol. 2016;231:2570\u201381.","journal-title":"J Cell Physiol"},{"key":"3992_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00383-005-1471-0","volume":"21","author":"S Sangkhathat","year":"2005","unstructured":"Sangkhathat S, Kusafuka T, Yoneda A, Kuroda S, Tanaka Y, Sakai N, et al. Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation. Pediatr Surg Int. 2005;21:745\u20138.","journal-title":"Pediatr Surg Int"},{"key":"3992_CR9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s00595-009-4145-z","volume":"40","author":"A Ohno","year":"2010","unstructured":"Ohno A, Mori A, Doi R, Yonenaga Y, Asano N, Uemoto S. Successful left hemihepatectomy and perioperative management of a patient with biliary cystadenocarcinoma, complicated with MELAS syndrome: Report of a case. Surg Today. 2010;40:878\u201382.","journal-title":"Surg Today."},{"key":"3992_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2141.2010.08332.x","volume":"152","author":"M Imaizumi","year":"2011","unstructured":"Imaizumi M, Tawa A, Hanada R, Tsuchida M, Tabuchi K, Kigasawa H, et al. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: The Japanese childhood acute myeloid leukaemia cooperative study. Br J Haematol. 2011;152:89\u201398.","journal-title":"Br J Haematol"},{"key":"3992_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.811406","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Wu R, Chen L, Yang Z, Yan D, Li M. Understanding anthracycline cardiotoxicity from mitochondrial aspect. Front Pharmacol. 2022;13: 811406.","journal-title":"Front Pharmacol"},{"key":"3992_CR12","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"A Lyon","year":"2022","unstructured":"Lyon A, L\u00f3pez-Fern\u00e1ndez T, Couch L, Asteggiano R, Aznar M, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229\u2013361.","journal-title":"Eur Heart J"},{"key":"3992_CR13","first-page":"1116","volume":"45","author":"S Sunaga","year":"1996","unstructured":"Sunaga S, Miyazaki K, Tsujino S, Koyama M, Koike Y, Horie R, et al. Clinical Investigation of Pirarubicin-induced Cardiac Dysfunction (in Japanese). J New Remedies Clin. 1996;45:1116\u201326.","journal-title":"J New Remedies Clin"},{"key":"3992_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00280-020-04045-9","volume":"85","author":"H Goto","year":"2020","unstructured":"Goto H, Yoshino Y, Ito M, Nagai J, Kumamoto T, Inukai T, et al. Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2020;85:773\u201383.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3992_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/bjh.17970","volume":"196","author":"T Yokosuka","year":"2022","unstructured":"Yokosuka T, Ito M, Yoshino Y, Hirose A, Nakamura W, Sakurai Y, et al. Using the in vitro drug sensitivity test to identify candidate treatments for transient abnormal myelopoiesis. Br J Haematol. 2022;196:764\u20138.","journal-title":"Br J Haematol"},{"key":"3992_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Cancer Discov. 2017;7:716\u201335.","journal-title":"Cancer Discov"},{"key":"3992_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-17-0476","volume":"7","author":"AD Schimmer","year":"2017","unstructured":"Schimmer AD. Novel mitochondrial mechanisms of cytarabine resistance in primary AML cells. Cancer Discov. 2017;7:670\u20132.","journal-title":"Cancer Discov"},{"key":"3992_CR18","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.bcp.2011.08.017","volume":"82","author":"E Calvi\u00f1o","year":"2011","unstructured":"Calvi\u00f1o E, Esta\u00f1 MC, Sim\u00f3n GP, Sancho P, Boyano-Ad\u00e1nez MC, de Blas E, et al. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells Reactive oxygen species generation and defensive protein kinase (MEK\/ERK, Akt\/mTOR) modulation. Biochem Pharmacol. 2011;82:1619\u201329.","journal-title":"Biochem Pharmacol."},{"key":"3992_CR19","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1038\/onc.2016.435","volume":"36","author":"M Dermit","year":"2017","unstructured":"Dermit M, Casado P, Rajeeve V, Wilkes EH, Foxler DE, Campbell H, et al. Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition. Oncogene. 2017;36:2762\u201374.","journal-title":"Oncogene"},{"key":"3992_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"3992_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s001250050950","volume":"41","author":"S Suzuki","year":"1998","unstructured":"Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia. 1998;41:584\u20138.","journal-title":"Diabetologia"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03992-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03992-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03992-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:21:55Z","timestamp":1757164915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03992-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3992"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03992-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}